Klisyri® (tirbanibulin) has been approved for topical AK treatment
Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis — Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp — Actinic keratosis is the second most common diagnosis made by dermatologists in the United States1 — In […]